Ardelyx reported $97.66M in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Abbott USD 11.42B 1.06B Jun/2025
Amgen USD 9.18B 1.03B Jun/2025
Ardelyx USD 97.66M 18.47M Jun/2025
Corcept Therapeutics USD 194.4M 37.2M Jun/2025
Life Technologies USD 2.22M 2.22M Jun/2025
Sanofi EUR 10.74B 529.51M Jun/2025
TG Therapeutics USD 141.1M 21.4M Jun/2025
United Therapeutics USD 798.6M 4.2M Jun/2025